These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32509183)
1. Expression levels of lncRNAs are prognostic for hepatocellular carcinoma overall survival. Xue C; Zhao Y; Jiang J; Li L Am J Transl Res; 2020; 12(5):1873-1883. PubMed ID: 32509183 [TBL] [Abstract][Full Text] [Related]
2. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
3. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma. Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL Front Oncol; 2020; 10():780. PubMed ID: 32587825 [No Abstract] [Full Text] [Related]
5. A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma. Zhang W; Fu Q; Yao K Oncol Lett; 2020 Oct; 20(4):48. PubMed ID: 32788937 [TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma. Lin P; Wen DY; Li Q; He Y; Yang H; Chen G Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571 [TBL] [Abstract][Full Text] [Related]
7. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets. Huang ZL; Li W; Chen QF; Wu PH; Shen LJ World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779 [TBL] [Abstract][Full Text] [Related]
8. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma. Ma Y; Luo T; Dong D; Wu X; Wang Y Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484 [TBL] [Abstract][Full Text] [Related]
9. Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma. Wang Z; Wu Q; Feng S; Zhao Y; Tao C PeerJ; 2017; 5():e3575. PubMed ID: 28729955 [TBL] [Abstract][Full Text] [Related]
10. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128 [TBL] [Abstract][Full Text] [Related]
11. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma. Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688 [TBL] [Abstract][Full Text] [Related]
12. Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma. Sui J; Miao Y; Han J; Nan H; Shen B; Zhang X; Zhang Y; Wu Y; Wu W; Liu T; Xu S; Yang S; Yin L; Pu Y; Liang G Cancer Med; 2018 Jul; 7(7):3240-3256. PubMed ID: 29761859 [TBL] [Abstract][Full Text] [Related]
13. A Co-Expression Network Reveals the Potential Regulatory Mechanism of lncRNAs in Relapsed Hepatocellular Carcinoma. Fang Y; Yang Y; Zhang X; Li N; Yuan B; Jin L; Bao S; Li M; Zhao D; Li L; Zeng Z; Huang H Front Oncol; 2021; 11():745166. PubMed ID: 34532296 [TBL] [Abstract][Full Text] [Related]
14. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma. Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs. Chow EY; Zhang J; Qin H; Chan TF Front Genet; 2019; 10():1081. PubMed ID: 31781161 [No Abstract] [Full Text] [Related]
16. Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs. Lin H; Xie Y; Kong Y; Yang L; Li M Front Mol Biosci; 2021; 8():625858. PubMed ID: 34888348 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma. Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431 [TBL] [Abstract][Full Text] [Related]
18. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Yan J; Zhou C; Guo K; Li Q; Wang Z J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981 [TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713 [TBL] [Abstract][Full Text] [Related]
20. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]